Vivimed Labs board recommends final dividend

Vivimed Labs has informed that the board of directors of the company at its meeting held on May 30, 2012, has recommended final dividend of 3.5% on compulsorily convertible and cumulative preference shares (CCPS's) on pro-rata basis for the financial year 2011-12. A final dividend of Rs 3 per share (30%) on equity shares for the financial year 2011-12.

The above information is part of company’s filing submitted to the BSE.